Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,273 recalls, newest first

Class II · Moderate risk

Captomer-250

Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.

Terminated Unapproved drug Thorne Research Inc D-1384-2014
Class II · Moderate risk

Captomer

Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.

Terminated Unapproved drug Thorne Research Inc D-1383-2014
Class II · Moderate risk

Carbidopa and Levodopa Tablets USP

Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.

Terminated Failed specification Teva Pharmaceuticals USA NDC 0093-0293-10 D-1538-2014
Class I · High risk

Soliris (eculizumab)

Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.

Terminated Particulate / foreign matter Alexion Pharmaceuticals, Inc. NDC 25682-001-01 D-1512-2014
Class II · Moderate risk

HCG 125U/Tab Tablet Tritu

Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.

Terminated Chemical / undeclared Brookfield Prescription Center Inc. dba MD Custom Rx D-1419-2014
Class II · Moderate risk

Diphenhydramine

Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.

Terminated Chemical / undeclared Brookfield Prescription Center Inc. dba MD Custom Rx D-1417-2014
Class II · Moderate risk

Fluvastatin Capsules USP

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.

Terminated Failed specification Teva Pharmaceuticals USA NDC 0093-7442-56 D-1430-2014
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification; out of specification result for particle size distribution during stability testing

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. NDC 0085-1401-01 D-1387-2014

Recalls by year